No Data
Allianz Real Estate (301042.SZ): Partial capital-raising projects delayed.
Gelonghui November 11th - Anlian Ruishi (301042.SZ) announced that the company held the sixteenth meeting of the fifth board of directors and the thirteenth meeting of the fifth board of supervisors on November 11, 2024, and passed the proposal on the extension of some raised funds investment projects, agreeing to postpone the company's investment in some raised funds investment projects. The construction project of the research and development center and the construction project of the marketing operation platform will be postponed until December 31, 2025.
BOC International: Body Asia Vets are expected to become the best carrier. Follow up on the commercialization path of body asia vets.
From the perspective of embodied intelligence training, simulation software can provide large amounts of low-cost data for large models, solving the high cost and difficult collection of real data problems, and simulation software is expected to achieve wide-ranging applications.
Anlian Ruiton (301042.SZ) plans to distribute profits in the third quarter with a dividend of 10 yuan per 10 shares.
Allianz Real Vision (301042.SZ) disclosed the profit distribution plan for the third quarter of 2024, proposing to distribute every 10 shares...
Zhuhai Raysharp TechnologyLtd's (SZSE:301042) Earnings Are Of Questionable Quality
November 4th A-share investment lightning rod | Shenzhen City: Shareholder Zhuhai Daoyuan intends to reduce shareholding by no more than 3%; Anlian Ruishi: Listed on the SDN list by the USA OFAC.
Shenzhen cdl precision technology's shareholders Zhuhai Daoyuan plan to reduce their shareholding by no more than 3%; Wuxi delinhai environmental technology's shareholder Chen Hong plans to reduce their shareholding by no more than 2%; Changzheng engineering technology's shareholders Guochuang Fund and Xinchexin Fund plan to collectively reduce their shareholding by no more than 3%; Joint water affairs related shareholder UW Holdings Limited plans to collectively reduce their shareholding by no more than 3%; Tianxin Pharmaceutical's actual controller and chairman Xu Jiangnan has been placed under investigation; special treat Boxin's stocks face the risk of delisting due to a market cap lower than 0.5 billion yuan; Anlai Ruishi has been included in the SDN list by the US OFAC; Shenzhen cdl precision technology's actual controller and senior management have received a notice of investigation from the CSRC.
Allianz Vision: Report for the third quarter of 2024
Benign Growth For Zhuhai Raysharp Technology Co.,Ltd. (SZSE:301042) Underpins Stock's 43% PlummetNo Data
No Data
